Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy
|更新时间:2024-01-04
|
Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 24, Pages: 295-300(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
LIU Xue-mei, TAN Zheng-huai, WANG Li, et al. Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 295-300.
DOI:
LIU Xue-mei, TAN Zheng-huai, WANG Li, et al. Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(24): 295-300.DOI:
Study on the Synergistic Effect between and in Control of Diabetic Cardiopathy
Objective:To study the synergistic effect between Gynostemma pentaphyllum (GP) and Scutellaria baicalensis Georgi (SBG) in control of diabetic cardiopathy(DC)
providing the scientific basis for the clinical application. Method: The in vitro effects of GP (0.5
5
50 mg·L-1)
SBG (0.5
5
50 mg·L-1) and the mixture of GP extract and SBG extract (GPSBG
0.5
5
50 mg·L-1) on vascular endothelial cells
myocardial cells and mesangial cells were investigated. Rat model of DC was induced by high fat feeding and injection of streptozotocin(STZ)of 25 mg·kg-1. The DC rats were randomly divided into GP 300 mg·kg-1
SBG 300 mg·kg-1
GPSBG 600 mg·kg-1 and DC model group. The investigation groups were respectively ig given corresponding extracts once daily for 8 weeks
while the controls and the models were given the same volume of sodium carboxy methyl cellulose (0.5%). The cardiac hemodynamic indexes and serum lipids were measured at 24 hours after the last administration. Result: SBG 5 mg·L-1and GPSBG 5 mg·L-1could compete the suppression of ECV-304 growth in 30 mmol·L-1 glucose
increasing NO generation
reduce GSH levels
compete the inhibition of mesangial cell proliferation in 30 mmol·L-1 glucose medium. SBG 5 mg·L-1
GP 5 mg·L-1 and GPSBG 5 mg·L-1could compete the suppression of ECV-304 growth
increase NO generation
reduce GSH levels by H2O2 on myocardial cell. GP 300 mg·kg-1and SBG 300 mg·kg-1 could decrease the cardiac index in typeⅡdiabetic rats
GPSBG 600 mg·kg-1 could significantly reduce the serum levels of TG and TC
index of heart in typeⅡdiabetic rats. GP 300 mg·kg-1 could significantly increase left ventricular systolic blood pressure and heart rate
left ventricular end-diastolic pressure
the rate index of left ventricular contraction and relaxation time
and lower left ventricular end-diastolic pressure. SBG 300 mg·kg-1could significantly reduce left ventricular end-diastolic pressure
GPSBG 600 mg·kg-1 could significantly increase heart rate
left ventricular systolic blood pressure
left ventricular contraction and relaxation time rate
reduce left ventricular end-diastolic pressure in typeⅡdiabetic rats. Conclusion: GP and SBG show synergistic effect on improving cardiac function in typeⅡdiabetic rats. This may be related to the effects of GP and SBG on reducing serum TG